Expression of nonclassical class I molecules by intestinal epithelial cells

Inflammatory Bowel Diseases

Volumn 13, Issue 3, 2007, Pages 298-307

  Perera, Lilani ^a   Shao, Ling ^a   Patel, Anjlee ^a   Evans, Kelly ^a   Meresse, Bertrand ^b   Blumberg, Richard ^c   Geraghty, Daniel ^d   Groh, Veronika ^d   Spies, Thomas ^d   Jabri, Bana ^b   Mayer, Lloyd ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Crohn's non classical class I molecules; Epithelium; IBD; Ulcerative colitis

Indexed keywords

CD1 ANTIGEN; HLA E ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIGEN PRESENTING CELL; ARTICLE; CD8+ T LYMPHOCYTE; CELIAC DISEASE; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; ULCERATIVE COLITIS;

ANTIGENS, CD1; CASE-CONTROL STUDIES; CELLS, CULTURED; COLITIS, ULCERATIVE; CROHN DISEASE; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; INTERFERON TYPE II; INTESTINAL MUCOSA; RNA, MESSENGER; T-LYMPHOCYTES, REGULATORY;

EID: 33947531049     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20026     Document Type: Article

References (71)

1. Kelleher D, Murphy A, Whelan CA, Feighery C, Weir DG, Keeling PW. Defective suppression in the autologous mixed lymphocyte reaction in patients with Crohn's disease. Gut. 1989;30:839-844.
2. Hodgson HJ, Wands JR, Isselbacher KJ. Decreased suppressor cell activity in inflammatory bowel disease. Clin Exp Immunol. 1978;32: 451-458.
3. Podolsky DK. Lessons from genetic models of inflammatory bowel disease. Acta Gastroenterol Belg. 1997;60:163-165.
4. Powrie F. T cells in inflammatory bowel disease: protective and pathogenic roles. Immunity. 1995;3:171-174.
5. Mayer L. Mucosal immunity and gastrointestinal antigen processing. J Pediatr Gastroenterol Nutr. 2000;30:S4-12.
6. Kaiserlian D. Murine gut epithelial cells express la molecules antigenically distinct from those of conventional antigen-presenting cells. Immunol Res. 1991;10:360-364.
7. Kaiserlian D, Vidal K, Revillard JP. Murine enterocytes can present soluble antigen to specific class II-restricted CD4+ T cells. Eur J Immunol. 1989;19:1513-1516.
8. Bland PW, Warren LG. Antigen presentation by epithelial cells of the rat small intestine. II. Selective induction of suppressor T cells. Immunology. 1986;58:9-14.
9. Bland PW. Antigen presentation by gut epithelial cells: secretion by rat enterocytes of a factor with IL-1-like activity. Adv Exp Med Biol. 1987:219-225.
10. Mayer L, Shlien R. Evidence for function of la molecules on gut epithelial cells in man. J Exp Med. 1987;166:1471-1483.
11. Panja A, Blumberg RS, Balk SP, Mayer L. CD1d is involved in T cell-intestinal epithelial cell interactions. J Exp Med. 1993;178:1115-1119.
12. Yio XY, Mayer L. Characterization of a 180-kDa intestinal epithelial cell membrane glycoprotein, gp180. A candidate molecule mediating t cell-epithelial cell interactions. J Biol Chem. 1997;272:12786-12792.
13. Li Y, Yio XY, Mayer L. Human intestinal epithelial cell-induced CD8+ T cell activation is mediated through CD8 and the activation of CD8-associated p56Ick. J Exp Med. 1995;182:1079-1088.
14. Campbell NA, Park MS, Toy LS, et al. A non-class I MHC intestinal epithelial surface glycoprotein, gp180, binds to CD8. Clin Immunol. 2002;102:267-274.
15. Campbell N, Yio XY, So LP, Li Y, Mayer L. The intestinal epithelial cell: processing and presentation of antigen to the mucosal immune system. Immunol Rev. 1999;172:315-324.
16. Campbell NA, Kim HS, Blumberg RS, Mayer L. The nonclassical class I molecule CD1d associates with the novel CD8 ligand gp180 on intestinal epithelial cells. J Biol Chem. 1999;274:26259-26265.
17. Lanier LL. NK cell recognition. Annu Rev Immunol. 2005;23:225-274.
18. Lopez-Botet M, Bellon T, Llano M, Navarro F, Garcia P, de Miguel M. Paired inhibitory and triggering NK cell receptors for HLA class I molecules. Hum Immunol. 2000;61:7-17.
19. Lopez-Botet M, Llano M, Navarro F, Bellon T. NK cell recognition of non-classical HLA class I molecules. Semin Immunol. 2000;12:109-119.
20. Bleicher PA, Balk SP, Hagen SJ, Blumberg RS, Flotte TJ, Terhorst C. Expression of murine CD1 on gastrointestinal epithelium. Science. 1990; 250:679-682.
21. Blumberg RS, Terhorst C, Bleicher P, et al. Expression of a nonpolymorphic MHC class I-like molecule, CD1D, by human intestinal epithelial cells. J Immunol. 1991;147:2518-2524.
22. Hershberg R, Eghtesady P, Sydora B, et al. Expression of the thymus leukemia antigen in mouse intestinal epithelium. Proc Natl Acad Sci U S A. 1990;87:9727-9731.
23. Roberts AI, Blumberg RS, Christ AD, Brolin RE, Ebert EC. Staphylococcal enterotoxin B induces potent cytotoxic activity by intraepithelial lymphocytes. Immunology. 2000;101:185-190.
24. Balk SP, Ebert EC, Blumenthal RL, et al. Oligoclonal expansion and CD1 recognition by human intestinal intraepithelial lymphocytes. Science. 1991;253:1411-1415.
25. Balk SP, Burke S, Polischuk JE, et al. Beta 2-microglobulin-independent MHC class lb molecule expressed by human intestinal epithelium. Science. 1994;265:259-262.
26. Kim HS, Colgan SP, Pitman R, Hershberg RM, Blumberg RS. Human CD1d associates with prolyl-4-hydroxylase during its biosynthesis. Mol Immunol. 2000;37:861-868.
27. Kim HS, Garcia J, Exley M, Johnson KW, Balk SP, Blumberg RS. Biochemical characterization of CD1d expression in the absence of beta2-microglobulin. J Biol Chem. 1999;274:9289-9295.
28. Somnay-Wadgaonkar K, Nusrat A, Kim HS, et al. Immunolocalization of CD1d in human intestinal epithelial cells and identification of a beta2-microglobulin-associated form. Int Immunol. 1999;11:383-392.
29. Rodionov DG, Nordeng TW, Kongsvik TL, Bakke O. The cytoplasmic tail of CD1d contains two overlapping basolateral sorting signals. J Biol Chem. 2000;275:8279-8282.
30. Zeng Z, Castano AR, Segelke BW, Stura EA, Peterson PA, Wilson IA. Crystal structure of mouse CD1: An MHC-like fold with a large hydrophobic binding groove. Science. 1997;277:339-345.
31. Zhou D, Mattner J, Cantu C 3rd, et al. Savage PB, Teyton L, Bendelac A. Lysosomal glycosphingolipid recognition by NKT cells. Science. 2004;306:1786-1789.
32. Allez M, Brimnes J, Dotan I, Mayer L. Expansion of CD8+ T cells with regulatory function after interaction with intestinal epithelial cells. Gastroenterology. 2002;123:1516-1526.
33. Koller BH, Geraghty DE, Shimizu Y, DeMars R, Orr HT. HLA-E. A novel HLA class I gene expressed in resting T lymphocytes. J Immunol. 1988;141:897-904.
34. Wei XH, Orr HT. Differential expression of HLA-E, HLA-F, and HLA-G transcripts in human tissue. Hum Immunol. 1990;29:131-142.
35. Lee N, Goodlett DR, Ishitani A, Marquardt H, Geraghty DE. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J Immunol. 1998;160: 4951-4960.
36. Geraghty DE, Stockschleader M, Ishitani A, Hansen JA. Polymorphism at the HLA-E locus predates most HLA-A and -B polymorphism. Hum Immunol. 1992;33:174-184.
37. Grimsley C, Ober C. Population genetic studies of HLA-E: evidence for selection. Hum Immunol. 1997;52:33-40.
38. Soloski MJ, DeCloux A, Aldrich CJ, Forman J. Structural and functional characteristics of the class IB molecule, Qa-1. Immunol Rev. 1995;147: 67-89.
39. O'Callaghan CA, Tormo J, Willcox BE, et al. Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E. Mol Cell. 1998;1:531-541.
40. Llano M, Lee N, Navarro F, et al. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer. Eur J Immunol. 1998; 28:2854-2863.
41. Vales-Gomez M, Reyburn HT, Erskine RA, Lopez-Botet M, Strominger JL. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E. EMBO J. 1999;18:4250-4260.
42. Borrego F, Ulbrecht M, Weiss EH, Coligan JE, Brooks AG. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med. 1998;187:813-818.
43. Lee N, Llano M, Carretero M, et al. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci U S A. 1998;95:5199-5204.
44. Braud VM, Allan DS, O'Callaghan CA, et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature. 1998;391:795-799.
45. Jabri B, Selby JM, Negulescu H, et al. TCR specificity dictates CD94/ NKG2A expression by human CTL. Immunity. 2002;17:487-499.
46. Jabri B, de Serre NP, Cellier C, et al. Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease. Gastroenterology. 2000;118:867-879.
47. Groh V, Bahram S, Bauer S, Herman A, Beauchamp M, Spies T. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci U S A. 1996;93:12445-12450.
48. Groh V, Steinle A, Bauer S, Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science. 1998;279:1737-1740.
49. Wu J, Groh V, Spies T. T cell antigen receptor engagement and specificity in the recognition of stress-inducible MHC class I-related chains by human epithelial gamma delta T cells. J Immunol. 2002;169:1236-1240.
50. Bauer S, Groh V, Wu J, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 1999;285:727-729.
51. Roberts AI, Lee L, Schwarz E, et al. NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment. J Immunol. 2001;167:5527-5530.
52. Meresse B. Chen Z, Ciszewski C, et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity. 2004;21: 357-366.
53. Groh V, Rhinehart R, Randolph-Habecker J, Topp MS, Riddell SR, Spies T. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol. 2001;2:255-260.
54. Wu J, Song Y, Bakker AB, et al. An activating immunoreceptor complex formed by NKG2D and DAP10. Science. 1999;285:730-732.
55. Mayer L, Eisenhardt D. Lack of induction of suppressor T cells by intestinal epithelial cells from patients with inflammatory bowel disease. J Clin Invest. 1990;86:1255-1260.
56. Kasai K, Matsuura A, Kikuchi K, Hashimoto Y, Ichimiya S. Localization of rat CD1 transcripts and protein in rat tissues - an analysis of rat CD1 expression by in situ hybridization and immunohistochemistry. Clin Exp Immunol. 1997;109:317-322.
57. Colgan SP, Morales VM, Madara JL, Polischuk JE, Balk SP, Blumberg RS. IFN-gamma modulates CD1d surface expression on intestinal epifhelia. Am J Physiol. 1996;271:C276-283.
58. Hue S, Mention JJ, Monteiro RC, et al. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity. 2004;21: 367-377.
59. Tieng V, Le Bouguenec C, du Merle L, et al. Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICA. Proc Natl Acad Sci USA. 2002;99:2977-2982.
60. Powrie F, Correa-Oliveira R, Mauze S, Coffman RL. Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Exp Med. 1994;179:589-600.
61. Roncarolo MG, Bacchetta R, Bordignon C, Narula S, Levings MK. Type 1 T regulatory cells. Immunol Rev. 2001;182:68-79.
62. Sakaguchi S, Toda M, Asano M, Itoh M, Morse SS, Sakaguchi N. T cell-mediated maintenance of natural self-tolerance: its breakdown as a possible cause of various autoimmune diseases. J Autoimmun. 1996;9: 211-220.
63. Sakaguchi S, Sakaguchi N, Shimizu J, et al. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev. 2001;182:18-32.
64. Shevach EM, Thornton A, Suri-Payer E. T lymphocyte-mediated control of autoimmunity. Novartis Found Symp. 1998;215:200-211; discussion 211-230.
65. Green DR, Webb DR. Saying the 'S' word in public. Immunol Today. 1993;14:523-525.
66. Toy LS, Yio XY, Lin A, Honig S, Mayer L. Defective expression of gp180, a novel CD8 ligand on intestinal epithelial cells, in inflammatory bowel disease. J Clin Invest. 1997;100:2062-2071.
67. Victorino RM, Hodgson HJ. Spontaneous suppressor cell function in inflammatory bowel disease. Dig Dis Sci. 1981;26:801-806.
68. Kelleher D, Murphy A, Whelan CA, Feighery C, Weir DG, Keeling PW. Defective suppression in the autologous mixed lymphocyte reaction in patients with Crohn's disease. Gut. 1989;30:839-844.
69. Goodacre RL, Bienenstock J. Reduced suppressor cell activity in intestinal lymphocytes from patients with Crohn's disease. Gastroenterology. 1982;82:653-658.
70. Ginsburg CH, Falchuk ZM. Defective autologous mixed-lymphocyte reaction and suppressor cell generation in patients with inflammatory bowel disease. Gastroenterology. 1982;83:1-9.
71. Duchmann R, Schmitt E, Knolle P, Meyer zum Buschenfelde KH, Neurath M. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur J Immunol. 1996;26:934-938.